Bank of New York Mellon’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.47M | Buy |
229,109
+17,799
| +8% | +$416K | ﹤0.01% | 2286 |
|
|
2026
Q1 | $4.03M | Sell |
211,310
-4,973
| -2% | -$110K | ﹤0.01% | 2439 |
|
|
2025
Q4 | $5.23M | Sell |
216,283
-4,562
| -2% | -$119K | ﹤0.01% | 2302 |
|
|
2025
Q3 | $5.63M | Sell |
220,845
-3,771
| -2% | -$89.5K | ﹤0.01% | 2246 |
|
|
2025
Q2 | $4.84M | Buy |
224,616
+2,827
| +1% | +$63.7K | ﹤0.01% | 2280 |
|
|
2025
Q1 | $5.07M | Sell |
221,789
-8,820
| -4% | -$232K | ﹤0.01% | 2211 |
|
|
2024
Q4 | $5.99M | Sell |
230,609
-4,612
| -2% | -$115K | ﹤0.01% | 2200 |
|
|
2024
Q3 | $5.89M | Sell |
235,221
-40,349
| -15% | -$953K | ﹤0.01% | 2216 |
|
|
2024
Q2 | $5.91M | Buy |
275,570
+8,216
| +3% | +$159K | ﹤0.01% | 2247 |
|
|
2024
Q1 | $4.96M | Sell |
267,354
-3,257
| -1% | -$57K | ﹤0.01% | 2334 |
|
|
2023
Q4 | $4.4M | Sell |
270,611
-4,690
| -2% | -$59.8K | ﹤0.01% | 2436 |
|
|
2023
Q3 | $3.8M | Sell |
275,301
-25,180
| -8% | -$397K | ﹤0.01% | 2459 |
|
|
2023
Q2 | $6.64M | Sell |
300,481
-5,759
| -2% | -$121K | ﹤0.01% | 2163 |
|
|
2023
Q1 | $6.66M | Sell |
306,240
-11,025
| -3% | -$248K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $5.77M | Sell |
317,265
-33,425
| -10% | -$690K | ﹤0.01% | 2260 |
|
|
2022
Q3 | $7.98M | Buy |
350,690
+15,206
| +5% | +$325K | ﹤0.01% | 2033 |
|
|
2022
Q2 | $4.63M | Buy |
335,484
+53,459
| +19% | +$784K | ﹤0.01% | 2353 |
|
|
2022
Q1 | $6.41M | Sell |
282,025
-13,005
| -4% | -$342K | ﹤0.01% | 2290 |
|
|
2021
Q4 | $11M | Sell |
295,030
-20,946
| -7% | -$899K | ﹤0.01% | 2053 |
|
|
2021
Q3 | $13.4M | Buy |
315,976
+207,476
| +191% | +$9.99M | ﹤0.01% | 1960 |
|
|
2021
Q2 | $4.83M | Buy |
108,500
+4,425
| +4% | +$156K | ﹤0.01% | 2509 |
|
|
2021
Q1 | $3.75M | Buy |
104,075
+35,221
| +51% | +$1.39M | ﹤0.01% | 2586 |
|
|
2020
Q4 | $2.75M | Buy |
68,854
+23,475
| +52% | +$800K | ﹤0.01% | 2660 |
|
|
2020
Q3 | $1.31M | Sell |
45,379
-43,415
| -49% | -$938K | ﹤0.01% | 2951 |
|
|
2020
Q2 | $1.45M | Sell |
88,794
-417
| -0.5% | -$5.75K | ﹤0.01% | 2877 |
|
|
2020
Q1 | $848K | Sell |
89,211
-1,465
| -2% | -$20.1K | ﹤0.01% | 3088 |
|
|
2019
Q4 | $1.47M | Buy |
90,676
+12,198
| +16% | +$198K | ﹤0.01% | 3022 |
|
|
2019
Q3 | $1.3M | Buy |
78,478
+973
| +1% | +$18.3K | ﹤0.01% | 3007 |
|
|
2019
Q2 | $1.31M | Buy |
77,505
+13,336
| +21% | +$233K | ﹤0.01% | 3048 |
|
|
2019
Q1 | $1.15M | Sell |
64,169
-761
| -1% | -$12.1K | ﹤0.01% | 3080 |
|
|
2018
Q4 | $781K | Buy |
64,930
+17,209
| +36% | +$206K | ﹤0.01% | 3244 |
|
|
2018
Q3 | $835K | Buy |
+47,721
| New | +$944K | ﹤0.01% | 3371 |
|
Other funds holding BLFS
CC
FAM
Bank of New York Mellon's BLFS Position: Q2 2026 in Review
Bank of New York Mellon increased its BioLife Solutions (BLFS) stake by 8.4% in Q2 2026, buying an estimated $416K and bringing the position to 229,109 shares worth $6.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2286.
Bank of New York Mellon first reported a position in BLFS in Q3 2018 and has held it in 32 quarters since. The position peaked at $13.4M in Q3 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.
- Bank of New York Mellon held 229,109 shares of BioLife Solutions worth $6.47M as of Q2 2026.
- Bank of New York Mellon bought 17,799 BioLife Solutions shares in Q2 2026, an estimated $416K.
- BioLife Solutions made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2286 holding.
- Bank of New York Mellon first reported a position in BioLife Solutions in Q3 2018 and has held it in 32 quarters since.
- Bank of New York Mellon's BioLife Solutions position peaked at $13.4M in Q3 2021.
- 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.